Catalyst Wire Dossier Catalyst Wire Dossier
EMA safety_alert · 2024-07-26

EMA advises about risks of using weight loss medicine Mysimba with opioids

View source ↗

Summary

The EMA warns that combining Mysimba (naltrexone/bupropion) with opioid medicines can cause serious safety risks, and people should avoid or manage this combina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mysimba (naltrexone/bupropion)

Snippet

Use of opioid medicines with Mysimba may lead to serious side effects